EmdexTrade PLC
23 July 2002
EMDEXTRADE PLC
INTERIM REPORT
2002
EMDEXTRADE PLC
UNAUDITED INTERIM RESULTS
FOR THE SIX MONTHS TO 30 APRIL 2002
WEBSITE
The website has taken longer to develop than was estimated and we currently
estimate going live in the fourth quarter of 2002.
MANAGEMENT
Ken Mackay has taken over as Managing Director from Stephen Corley who has
relocated to Dubai with a view to developing EmdexIslami FZ-LLC, a Dubai based
wholly owned subsidiary formed on 19 May 2002.
NEW DEVELOPMENTS
EmdexIslami FZ-LLC, which has not yet commenced trading, has been formed to
build a Shari'ah compliant web based trading platform primarily in order to
attract Islamic business and will utilise systems and technology developed by
EmdexTrade PLC.
EmdexTrade Delaware LLC, a New York based wholly owned subsidiary of EmdexTrade
PLC was formed on 13 June 2002 to act as a service company to Emerging Markets
Securities Delaware LLC, an NASD & SEC registered broker dealer company wholly
owned by Ken Mackay, also based in New York. EmdexTrade PLC looks forward with
confidence to developing regular cash flows which are anticipated as a result of
this transaction.
FUTURE PROSPECTS
The Directors believe that EmdexTrade PLC is now strategically placed to take
advantage of opportunities created by these developments to build a regular and
sustainable revenue stream. The company remains debt free with cash reserves of
£709,877 at 30 April 2002.
Ian Salter
Chairman
23 July 2002
EMDEXTRADE PLC
UNAUDITED PROFIT AND LOSS ACCOUNT
FOR THE SIX MONTHS TO 30 APRIL 2002
Six months to 30 Fifteen months to
April 2002 October 2001
(Unaudited) (Audited)
£ £
Turnover 119,356 312,865
Cost of sales (59,687) (100,617)
Gross profit 59,669 212,248
Administrative expenses (260,639) (302,539)
Operating loss (200,970) (90,291)
Interest receivable and similar income 18,186 20,938
Loss on ordinary activities before taxation (182,784) (69,353)
Tax on loss on ordinary activities 0 (825)
Loss on ordinary activities after taxation (182,784) (70,178)
Earnings per share
Basic earnings per share (0.46)p (0.49)p
Turnover is derived wholly from continuing activities
Notes:
1. The financial statements have been prepared in accordance with applicable UK
accounting standards and under the historical cost convention. The principal
accounting policies of the company are set out in the company's 2001 annual
report.
2. The financial information set out above does not constitute statutory
accounts as defined in section 240 of the Companies Act 1985. Statutory
accounts for the fifteen months to 31 October 2001, on which the report of
the auditors was unqualified, have been filed with the Registrar Of
Companies.
3. Earnings per share have been calculated on the basis of the number of shares
in issue of 40,000,000, which has remained unchanged during the period.
There are no diluted earnings per share.
4. The directors are not declaring a dividend for the period.
5. Copies of this report are being sent to all shareholders and can be viewed
on the company's web-site 'http://www.emdextrade.com/'
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.